

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $84.96
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 14, 26 |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 8, 26 | Albertini Andrea | officer: CEO, Global Dist. & Tech. | F-InKind | 603 @ $88.86 | $53.58K |
Daily · Wilder smoothing
| Leerink Partners |
| maintain |
| Market Perform |
| Market Perform |
| Aug 19, 26 | BTIG | maintain | Buy | Buy |
| Aug 6, 26 | Barclays | maintain | Overweight | Overweight |
| Aug 5, 26 | Citigroup | maintain | Buy | Buy |
| Aug 5, 26 | BTIG | maintain | Buy | Buy |
| Aug 5, 26 | UBS | maintain | Neutral | Neutral |
| Jul 29, 26 | Piper Sandler | maintain | Overweight | Overweight |
| Jul 28, 26 | UBS | maintain | Neutral | Neutral |
| Jun 11, 26 | BTIG | upgrade | Neutral | Buy |
| Sep 8, 26 |
| Albertini Andrea |
| officer: CEO, Global Dist. & Tech. |
| D-Return |
| 3,984 |
| — |
| Jun 12, 26 | Daniel William K | director | A-Award | 2,215 | — |
| May 21, 26 | Murphy Kelly Ann | officer: SVP & General Counsel | 0 | — |
| May 21, 26 | Murphy Kelly Ann | officer: SVP & General Counsel | 1,479 @ $62.71 | $92.75K |
| May 21, 26 | Murphy Kelly Ann | officer: SVP & General Counsel | 9,274 @ $76.76 | $711.9K |
| May 21, 26 | Murphy Kelly Ann | officer: SVP & General Counsel | 2,979 @ $86.27 | $257.0K |
| May 26, 26 | Bergman Stanley M | other: Former Director | G-Gift | 50 | — |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 47.43 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 67.96 | Oscillator | Neutral |
| Williams %R (14) | -36.19 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.34 (Hist 0.16) | Oscillator | Buy |
| Average Directional Index (14) | 18.97 (+DI 17.2 / -DI 22.6) | Trend | Neutral |
| EMA 20 | 85.35 | MA | Sell |
| SMA 20 | 84.95 | MA | Buy |
| EMA 50 | 85.80 | MA | Sell |
| SMA 50 | 86.95 | MA | Sell |
| SMA 200 | 80.86 | MA | Strong Buy |
FY2018 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2026 financial results before the stock market opens on Tuesday, November 3, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer, R.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Emmanuel Caprais, former Senior Vice President and Chief Financial Officer of ITT, Inc. (NYSE: ITT), has been named the Company's Senior Vice President and Chief Financial Officer effective November 4, 2026. Mr. Caprais will join the Henry Schein Leadership Team (HSLT) and report to Frederick M. Lowery, Chief Executive Officer of Henry Schein. To support a structured transition, Mr. Caprais will initially se.
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Cares, Henry Schein, Inc.'s global corporate citizenship program, is celebrating a quarter century of bringing together Team Schein Members, customers, supplier partners, healthcare professionals, nonprofit organizations, and communities to help make the world healthier. Today, Henry Schein Cares reflects the Company's broader approach to corporate citizenship through five interconnected pillars: Catalyzing Healthcare Access; Advancing Policies, Sol.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | 1.24 | 1.27 | Beat 2.4% | $3.46B |
| May 5, 2026 | 1.20 | 1.32 | Beat 10.0% | $3.37B |
| Feb 24, 2026 | 1.30 | 1.34 | Beat 3.1% | $3.44B |
| Nov 4, 2025 | 1.27 | 1.38 | Beat 8.7% | $3.34B |
| Aug 5, 2025 | 1.18 | 1.10 | Miss -6.8% | $3.24B |
| May 5, 2025 | 1.11 | 1.15 | Beat 3.6% | $3.17B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 8-K | Oct 8, 2026 | 2026-10-08 07:00:07 | View |
| 8-K | Sep 22, 2026 | 2026-09-22 06:35:26 | View |
| 4 | Sep 9, 2026 | 2026-09-09 16:33:13 | View |
| SC 13G | Aug 6, 2026 | 2026-08-06 10:28:18 | View |
| 10-Q | Aug 4, 2026 | 2026-08-04 11:58:59 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 06:13:53 | View |
| 8-K | Jul 30, 2026 | 2026-07-30 07:00:08 | View |
| 11-K | Jun 18, 2026 | 2026-06-18 09:09:05 | View |
| 4 | Jun 15, 2026 | 2026-06-15 16:29:31 | View |
| SD | May 29, 2026 | 2026-05-29 15:04:28 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | HSIC | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 24.6x | 21.5x · sector 20.7x | Elevated |
| Forward P/E (FY26E) | 15.8x | EPS est. 5.39 | Discount |
| Price / Book | 3.1x | 2.9x | In line |
| Price / Sales | 0.7x | 0.8x | In line |
| EV / EBITDA | 12.6x | 12.8x | In line |
| Return on equity | 12.4% | — | Healthy |
| Gross margin | 30.3% | 29.4% | In line |
| Debt / Equity | 1.21 | 0.70 | Moderate |
| Piotroski / Altman Z | 6/9 | Z 2.77 | Grey zone |
Discounted cash flow model